MADEDDU, Giuseppe
MADEDDU, Giuseppe
(111) In-pentetreotide SPECT/CT in gastroenteropancreatic (GEP)
2013-01-01 Spanu, Angela; Dore, F.; Piras, B.; Falchi, A.; Ferro, P.; Chessa, F.; Gelo, I.; Nuvoli, S.; Madeddu, Giuseppe
(111) In-pentetreotide SPECT/CT in pulmonary carcinoid (PC)
2013-01-01 O., Schillaci; Spanu, Angela; B., Piras; A., Falchi; R., Danieli; P., Ferro; A., Chiaravalloti; Nuvoli, Susanna Maria Francesca; F., Dore; Madeddu, Giuseppe
(99mTC)sestamibi and (99mTc)tetrofosmin in oncology: SPET and fusion imaging in lung cancer, malignant lymphomas and brain tumors
2005-01-01 Schillaci, O; Spanu, Angela; Madeddu, Giuseppe
111In pentetreotide SPECT/CT in neuroendocrine tumor (NETs) diagnostic management.
2015-01-01 Spanu, A.; Schillaci, O.; Piras, B.; Falchi, A.; Danieli, R.; Ferro., P.; Nuvoli, S.; Dore, F.; Madeddu, G.
111In-pentetreotide SPECT and SPECT/CT vs conventional imaging procedures (CIP) in non-functioning gastroenteropancreatic neuroendocrine tumor (GEP) patient management.
2011-01-01 Spanu, Angela; O., Schillaci; A., Falchi; R., Danieli; G. B., Di Santo; P., Marongiu; F., Chessa; Nuvoli, Susanna Maria Francesca; F., Dore; Madeddu, Giuseppe
111In-pentetreotide SPECT/CT for functional anatomical mapping in patients with pulmonary carcinoid.
2013-01-01 A., Chiaravalloti; Spanu, Angela; F., Dore; R., Danieli; A., Falchi; P., Ferro; M., Tavolozza; O., Schillaci; Madeddu, Giuseppe
111In-Pentetreotide SPECT/CT in neuroendocrine gastroenteropancreatic (GEP) tumors
2013-01-01 Spanu, Angela; Dore, F.; Falchi, A.; Piras, B.; Ferro, P.; Chessa, F.; Gelo, I.; Mele, L.; Nuvoli, S.; Madeddu, Giuseppe
111InPentetreotide SPECT and SPECT/CT in non functioning gastroenteropancreatic neuroendocrine tumors (GEP).
2011-01-01 Spanu, A.; Schillaci, O.; Falchi, A.; Danieli, R.; Marongiu, P.; Chessa, F.; Nuvoli, S.; Madeddu, Giuseppe
12. Prolactin (PRL) response to Thyrotropin Releasing Hormone (TRH) in patients with subacute thyroiditis in the early stage.
1981-01-01 Madeddu, Giuseppe; M., Langer; C., Costanza; M., Piga; A. R., Casu
123I FP-CIT SPECT and 99mTc HM-PAO SPECT combined use in patients with associated movement and cognitive disorders
2006-01-01 Nuvoli, S.; Agnetti, V.; Nieddu, A.; Paulus, K.; Solinas, M. E.; Falchi, A.; Chessa, F.; Spanu, Angela; Madeddu, Giuseppe
123I FP-CIT SPECT in early Parkinson’s disease
2007-01-01 Nuvoli, S; Agnetti, V; Paulus, K; Chessa, F; Solinas, Me; Falchi, A; Spanu, Angela; Madeddu, Giuseppe
123I Ioflupane SPECT in the differential diagnosis of Lewy bodies Dementia
2008-01-01 Nuvoli, S.; Nieddu, A.; Rotondo, A.; Salvo, R.; Rubattu, E.; Chessa, F.; Spanu, Angela; Madeddu, Giuseppe
123I-FP-CIT brain SPECT data by means of a support vector machine classifier (SVM) to diagnose Parkinson’s disease.
2013-01-01 Palumbo, B.; Nuvoli, S.; Pompili, F.; Fravolini, M. L.; Sabalich, I.; Tambasco, N.; Spanu, A.; Madeddu, Giuseppe
123I-FP-CIT brain SPECT: tracer uptake values of right putamen are the most discriminant to diagnose Parkinson’s disease.
2016-01-01 Palumbo, B; Cascianelli, S; Sanonicola, A; Minestrini, M; Buresta, T; Fravolini, Ml; Tambasco, N; Scialpi, M; Nuvoli, S; Spanu, A; Madeddu, G.
123I-FP-CIT SPECT in the diagnosis of Parkinson’s disease in early stage.
2006-01-01 Nuvoli, S.; Agnetti, V.; P., Kai; F., Chessa; A., Spanu; Madeddu, Giuseppe
123I-FP-CIT SPECT usefulness in early stage Parkinson’s Disease
2005-01-01 Nuvoli, S.; Agnetti, V.; Paulus, K.; Sanna, L.; Falchi, A.; Chessa, F.; Spanu, Angela; Madeddu, Giuseppe
123I-FP-CIT SPECT: a new diagnostic method for Parkinson Disease
2004-01-01 Nuvoli, S.; Agnetti, V.; Paulus, K.; Sanna, L.; Sechi, Gianpietro; Falchi, A.; Chessa, F.; Pisu, N.; Spanu, Angela; Madeddu, Giuseppe
123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders
2017-01-01 Nuvoli, Susanna Maria Francesca; Spanu, Angela; Piras, Maria Rita; Nieddu, Antonio; Aldo, Mulas; Rocchitta, Gaia Giovanna Maria; Galleri, Grazia; Serra, Pier Andrea; Madeddu, Giuseppe
123I-Ioflupane SPECT reduced parental glutathione (GSH) therapy evaluation in Parkinson’s disease (PD)
2008-01-01 Nuvoli, S.; Sechi, G. B.; Agnetti, V.; Paulus, K.; Chessa, F.; Cocco, G.; Spanu, Angela; Madeddu, Giuseppe
123I-MetalodoBenzylGuanidine (123I-MIBG) cardiac scintigraphy in the differential diagnosis of neurodegenerative movements disorders
2013-01-01 Nuvoli, S.; Piras, M. R.; Nieddu, A.; Dachena, G.; Spanu, Angela; Madeddu, Giuseppe
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| (111) In-pentetreotide SPECT/CT in gastroenteropancreatic (GEP) | 1-gen-2013 | Spanu, Angela; Dore, F.; Piras, B.; Falchi, A.; Ferro, P.; Chessa, F.; Gelo, I.; Nuvoli, S.; Madeddu, Giuseppe | |
| (111) In-pentetreotide SPECT/CT in pulmonary carcinoid (PC) | 1-gen-2013 | O., Schillaci; Spanu, Angela; B., Piras; A., Falchi; R., Danieli; P., Ferro; A., Chiaravalloti; Nuvoli, Susanna Maria Francesca; F., Dore; Madeddu, Giuseppe | |
| (99mTC)sestamibi and (99mTc)tetrofosmin in oncology: SPET and fusion imaging in lung cancer, malignant lymphomas and brain tumors | 1-gen-2005 | Schillaci, O; Spanu, Angela; Madeddu, Giuseppe | |
| 111In pentetreotide SPECT/CT in neuroendocrine tumor (NETs) diagnostic management. | 1-gen-2015 | Spanu, A.; Schillaci, O.; Piras, B.; Falchi, A.; Danieli, R.; Ferro., P.; Nuvoli, S.; Dore, F.; Madeddu, G. | |
| 111In-pentetreotide SPECT and SPECT/CT vs conventional imaging procedures (CIP) in non-functioning gastroenteropancreatic neuroendocrine tumor (GEP) patient management. | 1-gen-2011 | Spanu, Angela; O., Schillaci; A., Falchi; R., Danieli; G. B., Di Santo; P., Marongiu; F., Chessa; Nuvoli, Susanna Maria Francesca; F., Dore; Madeddu, Giuseppe | |
| 111In-pentetreotide SPECT/CT for functional anatomical mapping in patients with pulmonary carcinoid. | 1-gen-2013 | A., Chiaravalloti; Spanu, Angela; F., Dore; R., Danieli; A., Falchi; P., Ferro; M., Tavolozza; O., Schillaci; Madeddu, Giuseppe | |
| 111In-Pentetreotide SPECT/CT in neuroendocrine gastroenteropancreatic (GEP) tumors | 1-gen-2013 | Spanu, Angela; Dore, F.; Falchi, A.; Piras, B.; Ferro, P.; Chessa, F.; Gelo, I.; Mele, L.; Nuvoli, S.; Madeddu, Giuseppe | |
| 111InPentetreotide SPECT and SPECT/CT in non functioning gastroenteropancreatic neuroendocrine tumors (GEP). | 1-gen-2011 | Spanu, A.; Schillaci, O.; Falchi, A.; Danieli, R.; Marongiu, P.; Chessa, F.; Nuvoli, S.; Madeddu, Giuseppe | |
| 12. Prolactin (PRL) response to Thyrotropin Releasing Hormone (TRH) in patients with subacute thyroiditis in the early stage. | 1-gen-1981 | Madeddu, Giuseppe; M., Langer; C., Costanza; M., Piga; A. R., Casu | |
| 123I FP-CIT SPECT and 99mTc HM-PAO SPECT combined use in patients with associated movement and cognitive disorders | 1-gen-2006 | Nuvoli, S.; Agnetti, V.; Nieddu, A.; Paulus, K.; Solinas, M. E.; Falchi, A.; Chessa, F.; Spanu, Angela; Madeddu, Giuseppe | |
| 123I FP-CIT SPECT in early Parkinson’s disease | 1-gen-2007 | Nuvoli, S; Agnetti, V; Paulus, K; Chessa, F; Solinas, Me; Falchi, A; Spanu, Angela; Madeddu, Giuseppe | |
| 123I Ioflupane SPECT in the differential diagnosis of Lewy bodies Dementia | 1-gen-2008 | Nuvoli, S.; Nieddu, A.; Rotondo, A.; Salvo, R.; Rubattu, E.; Chessa, F.; Spanu, Angela; Madeddu, Giuseppe | |
| 123I-FP-CIT brain SPECT data by means of a support vector machine classifier (SVM) to diagnose Parkinson’s disease. | 1-gen-2013 | Palumbo, B.; Nuvoli, S.; Pompili, F.; Fravolini, M. L.; Sabalich, I.; Tambasco, N.; Spanu, A.; Madeddu, Giuseppe | |
| 123I-FP-CIT brain SPECT: tracer uptake values of right putamen are the most discriminant to diagnose Parkinson’s disease. | 1-gen-2016 | Palumbo, B; Cascianelli, S; Sanonicola, A; Minestrini, M; Buresta, T; Fravolini, Ml; Tambasco, N; Scialpi, M; Nuvoli, S; Spanu, A; Madeddu, G. | |
| 123I-FP-CIT SPECT in the diagnosis of Parkinson’s disease in early stage. | 1-gen-2006 | Nuvoli, S.; Agnetti, V.; P., Kai; F., Chessa; A., Spanu; Madeddu, Giuseppe | |
| 123I-FP-CIT SPECT usefulness in early stage Parkinson’s Disease | 1-gen-2005 | Nuvoli, S.; Agnetti, V.; Paulus, K.; Sanna, L.; Falchi, A.; Chessa, F.; Spanu, Angela; Madeddu, Giuseppe | |
| 123I-FP-CIT SPECT: a new diagnostic method for Parkinson Disease | 1-gen-2004 | Nuvoli, S.; Agnetti, V.; Paulus, K.; Sanna, L.; Sechi, Gianpietro; Falchi, A.; Chessa, F.; Pisu, N.; Spanu, Angela; Madeddu, Giuseppe | |
| 123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders | 1-gen-2017 | Nuvoli, Susanna Maria Francesca; Spanu, Angela; Piras, Maria Rita; Nieddu, Antonio; Aldo, Mulas; Rocchitta, Gaia Giovanna Maria; Galleri, Grazia; Serra, Pier Andrea; Madeddu, Giuseppe | |
| 123I-Ioflupane SPECT reduced parental glutathione (GSH) therapy evaluation in Parkinson’s disease (PD) | 1-gen-2008 | Nuvoli, S.; Sechi, G. B.; Agnetti, V.; Paulus, K.; Chessa, F.; Cocco, G.; Spanu, Angela; Madeddu, Giuseppe | |
| 123I-MetalodoBenzylGuanidine (123I-MIBG) cardiac scintigraphy in the differential diagnosis of neurodegenerative movements disorders | 1-gen-2013 | Nuvoli, S.; Piras, M. R.; Nieddu, A.; Dachena, G.; Spanu, Angela; Madeddu, Giuseppe |